Product Description
Overall, the global endoscopic retrograde cholangiopancreatography (ERCP) device market was valued at nearly $1.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 6.1% to reach nearly $2.6 billion.
The full report suite on the global market for ERCP devices includes sphincterotomes, biliary stone removal balloons, biliary stone removal baskets, biliary dilation balloons, biliary and pancreatic stents, biliary lithotripters, ERCP guidewires and ERCP cannulas.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
ERCP procedures saw a strong increase in 2021, as procedures delayed due to COVID-19 were able to be conducted. Across the forecast period, procedural growth is expected to return to pre-COVID-19 levels, showing steady growth in the coming years.
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICE MARKET TRENDS
In 2021, the largest segment of the ERCP device market was the biliary and pancreatic stent market. This segment has experienced significant growth since Boston Scientific acquired Xlumena in 2015 and began marketing its AXIOS™ lumen-apposing covered-metal stent.
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICE MARKET SHARE INSIGHTS
Overall, within the global ERCP device market there are three dominant competitors: Boston Scientific, Olympus, Cook Medical.
In 2021, the leading competitor in the ERCP device market was Boston Scientific, with around half of the total global market share. Boston Scientific has experienced significant growth since acquiring Xlumena and its AXIOS™ lumen-apposing covered-metal stent in 2015.
MARKET SEGMENTATION SUMMARY
-
Sphincterotome
-
Biliary Stone Removal Balloon
-
Biliary Stone Removal Basket
-
Biliary Dilation Balloon
-
Biliary and Pancreatic Stent
-
Biliary Lithotripter
-
ERCP Guidewire
-
ERCP Cannula
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast Period | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavor never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
